This test is most useful if any of these apply to you.
Vitamin B6 helps your body break down tryptophan. When B6 is inadequate, that process can change, sometimes increasing the amount of xanthurenic acid passed in urine. This is the basis for studying urinary xanthurenic acid as a functional marker of B6 status.
The strongest evidence comes from tests performed after a large dose of tryptophan. A routine urine sample measures the compound without that challenge, and its ability to identify a B6 shortfall is less well established. For nutritional and preventive screening, this remains an exploratory marker. A high result doesn't establish a deficiency, and there is no validated urinary target linked to better health or longer life.
Much of the tryptophan your body breaks down passes through the kynurenine pathway. This is a series of chemical reactions that can contribute to making NAD, a molecule involved in releasing energy from food. Xanthurenic acid forms on a side branch of that pathway.
One branch uses an enzyme called kynureninase, while another turns an intermediate product into xanthurenic acid. Both reactions need vitamin B6. During B6 depletion, kynureninase can lose activity more readily than the enzyme making xanthurenic acid. This helps explain why urinary excretion can increase after a tryptophan challenge. It doesn't mean every degree of B6 inadequacy produces a predictable change in an ordinary urine sample.
Historical studies used urinary xanthurenic acid to assess how the body handled an added supply of tryptophan. These challenge studies support a connection with B6-dependent metabolism, but hormones, medications, illness, and collection conditions also influence the result. Even the challenge test has limits as a stand-alone measure of B6 status.
The better-established blood marker is pyridoxal 5′-phosphate, usually called PLP. PLP is an active form of vitamin B6. Its concentration also changes with inflammation and other health conditions, so a low blood result doesn't always mean your diet contains too little B6. Blood and urine measurements can provide different information, but combining them hasn't been shown to make routine spot-urine screening a definitive test of deficiency.
An older study compared fasting urine from 10 people with type 2 diabetes and 10 people without it. Xanthurenic acid relative to urine creatinine was higher in the diabetes group. This was an unchallenged urine measurement, making it more relevant to routine urine testing than a tryptophan-load study. Its small size and observational design still leave it far short of establishing a screening test for insulin resistance or diabetes.
B6 status may be part of this relationship. In a separate study, low circulating PLP was found in nearly two thirds of participants with type 2 diabetes and early kidney damage, compared with about a quarter of controls. These were blood B6 measurements, not urinary xanthurenic acid results. They support examining B6 metabolism in diabetes, but don't show that urinary xanthurenic acid identifies the cause of blood sugar problems.
Urinary xanthurenic acid reflects production, kidney handling, and urine concentration. A blood concentration measures a different part of that process, so findings from serum or plasma can't be transferred directly to your urine result.
In a study of chronic kidney disease, higher serum xanthurenic acid accompanied worse kidney filtration. In a separate cohort of people with type 2 diabetes, higher plasma xanthurenic acid was associated with a lower risk of progressing to kidney failure after adjustment for other risk factors. The studies involved different populations and disease settings. They don't establish a protective effect of raising xanthurenic acid, or a direction of kidney risk that can be assigned to a routine urine result.
Inflammation can change tryptophan breakdown and circulating B6 levels. That makes it relevant to interpretation, but it doesn't produce a uniform rise in urinary xanthurenic acid. A high urine result and a low blood B6 result can also occur together during inflammatory illness.
A retrospective analysis of 17,834 people with chronic pain found that about one in six had urinary xanthurenic acid flagged as elevated by the study's laboratory criteria. The participants were a selected group undergoing commercial testing, and medication use and other possible causes weren't adequately evaluated. The finding doesn't establish how many had B6 deficiency, what caused their pain, or whether treating the urine result would help.
Small studies have reported altered xanthurenic acid in several psychiatric and developmental conditions. One study found higher urinary levels in 30 young autistic children compared with 30 controls. A separate schizophrenia study found lower serum levels in affected people and their unaffected close relatives. The specimen types and study populations differed, so these findings don't establish a common pattern.
Laboratory and animal experiments have investigated how xanthurenic acid interacts with brain signaling. Those experiments don't establish what a urine result means for activity in your brain. Urinary testing hasn't been validated to diagnose depression, ADHD, schizophrenia, or autism, or to select treatment for them.
An unusually large amount of xanthurenic acid in urine can occur with an inherited defect in KYNU, the gene that provides instructions for making kynureninase. A family report described two brothers with this defect and marked urinary abnormalities, although neither had signs of niacin deficiency at the time of the report. This rare disorder is considered from the broader metabolic pattern and clinical history, not from an isolated modest increase.
A small historical study found poor repeatability when healthy volunteers repeated a tryptophan-load test within a week. Collection timing also affected variability. That finding cautions against overinterpreting challenge results; it doesn't quantify the repeatability of a modern routine spot test or prove that frequent testing improves decisions.
Evidence-backed interventions that affect your Xanthurenic Acid level
Xanthurenic Acid is best interpreted alongside these tests.
Xanthurenic Acid is included in these pre-built panels.
See the chemical trail your metabolism leaves behind, and explore where your energy, gut, and nutrient pathways may be under strain.
A comprehensive at-home nutritional and metabolic assessment that analyzes key biomarkers to reveal functional nutrient needs and imbalances.
90 biomarkers